• Home
  • Contact
  • How to get there
  • Glossary
  • FAQ
  • Imprint
MGC Munich
Skip navigation
  • The MGZ
    • The MGZ
    • Contact Persons
    • Consultation Hours
    • Vacancies
    • Quality Management
    • Publications
    • Partners
  • Diagnostics
    • Cytogenetic and Molecularcytogenetic Diagnostics
    • Moleculargenetic Diagnostics
  • Genetic Counselling
  • Shipment Information
  • Events
  • News
  • Downloads
 
  • Molekulargenetische Diagnostik
Download Request Forms of Diagnostics (GERMAN)

Molekulargenetische Diagnostik

Moleculargenetic Diagnostics

Contact person for molecular genetics tests

Frau Birgit Neitzel
Tel. +49 (0)89/30 90 886-553

MGZ
Medical Genetics Center

Bayerstraße 3-5 (durch die Mathäser-Passage)

Eingang Schlosserstraße 6
80335 München
info@mgz-muenchen.de
Tel. +49 (0)89/30 90 886-0
Fax +49 (0)89/30 90 886-66

Head
Prof. Dr. med. Dipl. chem. Elke Holinski-Feder

Moleculargenetic Diagnostics

back to the list

Hereditary tumour diseases, gastroenterology

Prof. Dr. med. Elke Holinski-Feder, Brigitte Schönfeld, Ärztin, Dr. rer. nat. Andreas Laner

Adenomatous Polyposis coli, FAP - APC

Adenomatous Polyposis coli, MAP - MUTYH

Birt-Hogg-Dubé Syndrome - FLCN

Breast and Ovarial Carcinoma - BRCA1, BRCA2, ATM, CHEK2, RAD51C

Carney Complex - PRKAR1A

Constitutive MMR-defiziency (CMMR-D) syndrome

Cowden Syndrome - PTEN

Gastric Cancer, Diffuse - CDH1

Gorlin Syndrome - PTCH1

HNPCC - MLH1, MSH2, MSH6, PMS2

Juvenile Polyposis coli - BMPR1A, SMAD4, ENG

Leiomyomatosis, HLRCC - FH

Li-Fraumeni Syndrome - p53

Malignant Melanoma - CDKN2A (p16)

Microsatellite analysis from tumor tissue

Morbus Crohn - CARD15

Morbus Osler - ENG, ACVRL1

Multiple Endocrine Neoplasia Type 1, MEN 1 - MEN1

Multiple Endocrine Neoplasia Type 2A, MEN 2A - RET

Multiple Endocrine Neoplasia Type 2B, MEN2B - RET

Pancreas Carcinoma, FPC - PALB2, p16

Pankreatitis - PRSS1, SPINK1, CFTR

Paragangliom-Pheochromocytoma Syndrome Typ PGL1, PGL4 - SDHB, SDHD

Peutz-Jeghers Syndrome - STK11

Schwannomatosis - SMARCB1

Von-Hippel-Lindau Syndrome - VHL

Wilms Tumor, Nephroblastoma - WT1

back to the list

Das MGZ folgt den Empfehlungen der Gesellschaft für Humangenetik (GfH) und nimmt regelmäßig und mit Erfolg an externen qualitätssichernden
Maßnahmen (BVDH, EMQN) teil. Stand 07.02.2012 © MGZ - Medizinisch Genetisches Zentrum